We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Alcon (ALC) Outperforming Other Medical Stocks This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Alcon (ALC - Free Report) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Alcon is one of 1109 individual stocks in the Medical sector. Collectively, these companies sit at #6 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Alcon is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for ALC's full-year earnings has moved 4.3% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the latest available data, ALC has gained about 14.2% so far this year. Meanwhile, the Medical sector has returned an average of -8.8% on a year-to-date basis. This shows that Alcon is outperforming its peers so far this year.
One other Medical stock that has outperformed the sector so far this year is Molina (MOH - Free Report) . The stock is up 1.3% year-to-date.
For Molina, the consensus EPS estimate for the current year has increased 2.6% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Breaking things down more, Alcon is a member of the Medical - Instruments industry, which includes 95 individual companies and currently sits at #106 in the Zacks Industry Rank. This group has lost an average of 9.1% so far this year, so ALC is performing better in this area.
On the other hand, Molina belongs to the Medical - HMOs industry. This 7-stock industry is currently ranked #80. The industry has moved -4.6% year to date.
Investors with an interest in Medical stocks should continue to track Alcon and Molina. These stocks will be looking to continue their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is Alcon (ALC) Outperforming Other Medical Stocks This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Alcon (ALC - Free Report) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Alcon is one of 1109 individual stocks in the Medical sector. Collectively, these companies sit at #6 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Alcon is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for ALC's full-year earnings has moved 4.3% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the latest available data, ALC has gained about 14.2% so far this year. Meanwhile, the Medical sector has returned an average of -8.8% on a year-to-date basis. This shows that Alcon is outperforming its peers so far this year.
One other Medical stock that has outperformed the sector so far this year is Molina (MOH - Free Report) . The stock is up 1.3% year-to-date.
For Molina, the consensus EPS estimate for the current year has increased 2.6% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Breaking things down more, Alcon is a member of the Medical - Instruments industry, which includes 95 individual companies and currently sits at #106 in the Zacks Industry Rank. This group has lost an average of 9.1% so far this year, so ALC is performing better in this area.
On the other hand, Molina belongs to the Medical - HMOs industry. This 7-stock industry is currently ranked #80. The industry has moved -4.6% year to date.
Investors with an interest in Medical stocks should continue to track Alcon and Molina. These stocks will be looking to continue their solid performance.